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Abstract: Although radon is a well-established contributor to lung cancer mortality among uranium
miners, the effects of radon decay products on different histopathologies of lung carcinoma are not
well established. Using a retrospective cohort design, this study aims to examine the risks of lung
cancer by histological subtypes associated with exposure to radon decay products among the Ontario
Uranium Miners cohort. Cases were stratified by histological groups, and associated risks were
estimated for cumulative radon exposure after adjustment for attained age and calendar period.
Between 1969 and 2005, 1274 incident cases of primary lung cancer were identified. Of these, 1256
diagnoses (99%) contained information on histology. Squamous cell carcinoma was most common
(31%), followed by adenocarcinoma (20%), large cells (18%), small cell lung carcinoma (14%), and
other or unspecified cell types (17%). Of the histological sub-groups, small cell lung carcinoma had
the strongest association with cumulative radon exposure; compared to the reference group (<1
cumulative working level months (WLM)), the highest exposure category (>60 cumulative WLM)
had a relative risk (RR) of 2.76 (95% CI: 1.67–4.57). Adenocarcinoma had the lowest risk and was
not significantly associated with exposure to radon decay products (RR = 1.49, 95% CI: 0.96–2.31).
An increasing, linear trend in relative risk was noted with increasing cumulative WLM across small
cell, squamous cell, and large cell lung carcinomas (Ptrend < 0.05). Similarly, the excess relative risk
(ERR) per WLM was highest for small cell lung carcinoma (ERR/WLM = 0.15, p < 0.01), followed by
squamous cell carcinoma (ERR/WLM = 0.12, p < 0.01). Non-statistically significant excess risk was
observed for adenocarcinoma (ERR/WLM = 0.004, p = 0.07). Our analysis of the Ontario Uranium
Miners cohort data shows differences in the magnitude of the risks across four histological subtypes
of lung carcinoma; the strongest association was noted for small cell lung carcinoma, followed by
squamous cell, large cell, and lastly adenocarcinoma, which showed no significant associations with
exposure to radon decay products.
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1. Introduction
Radon is a well-established risk factor for lung cancer, particularly among uranium miners [1–4].
Excess risks for lung cancer mortality associated with radon exposure have been consistently
demonstrated in uranium miner cohorts in the United States [5,6], France [7–9], Czechoslovakia [10–12],
Germany [13–15], and other non-uranium mining cohorts [16,17]. Consistent with the international
literature, our recent update of the Ontario Uranium Miners cohort also found an excess lung cancer
risk, which persisted many years after leaving the mining industry [18].
Studies on the risk of lung cancer associated with radon exposure have historically been focused
on mortality rather than incident cases. Cancer incidence is preferred because it is captured from
tumour registries rather than death certificates, which has the advantage of providing more detailed
information at the time of diagnosis, such as the behavior, morphology, and topology. Since not
all lung cancer diagnoses resulted in mortality, incident cases provide a better estimate of the true
effect of radon. From a statistical perspective, incident cases would provide a large case count, which
provides more statistical power to detect an effect, if one truly exists. The additional statistical power
allows for evaluation of lung cancer risks by different histologic subtypes in this study. With lung
cancer morphology, there are four main histological sub-classifications: small cell carcinoma (SmCC),
squamous cell carcinoma (SqCC), adenocarcinoma (AdC), and large cell carcinoma (LCC).
Histology-specific estimates of lung cancer risk are important to better understand the etiology
and the role of radon decay products in lung cancer development. Globally, radon is the second
leading cause of lung cancer, after smoking [19]. Among the male population in the United States,
adenocarcinoma is the most common lung cancer subtype, accounting for 40% of all lung cancer
cases [20]. In contrast, occupational cohorts show the most common histological subtype was squamous
cell carcinoma (43%), and adenocarcinoma only accounted for 23% of all cases [21]. Differences in the
proportions of histological subtypes between the general population and occupational groups implicate
a different role of occupational exposures, such as radon, on the etiology of lung cancer development.
Similarly, in an earlier study of the Ontario Uranium Miners cohort, 20% of tissue samples
showed adenocarcinoma, whereas the majority of the deaths were due to squamous cell and small cell
carcinomas [22]. Although the lung cancer risks across lung cancer histological subtypes has not been
assessed among the Ontario Uranium Miners cohort, strong associations were observed for squamous
cell and small cell carcinoma among German and Czech cohorts of uranium miners [21,23]. Given that
high linear energy transfer radiation is emitted during the radon decay process, it can be hypothesized
that epithelial tumours (e.g., squamous cell and small cell carcinomas) would occur at a higher rate
than adenocarcinoma among miners [24,25].
Mining of uranium ore in Ontario, Canada began in 1954 and continued operations until 1996,
employing over 28,000 men during this period. The cohort file has recently been updated to extend the
follow-up period to the end of 2007, providing more power to examine the risk of lung cancer across
histological subtypes. This study presents a large cohort with detailed follow-up data and sufficient
statistical power to evaluate histological-specific lung cancer risks. As such, the objective of this study
is to evaluate the risk of lung carcinoma associated with exposure to short-lived radon progeny by
histological subtypes among a cohort of Ontario uranium miners.
2. Materials and Methods
2.1. Study Population
This is a retrospective cohort study that includes all miners who worked at least one week in
an Ontario uranium mine. Miners were excluded if they: were a probable duplicate; did not have
a recorded date of birth; entered the cohort after 31 December 1996; were younger than 15 or older
than 65 at first employment; had invalid dates of employment or cancer diagnosis. Very few women
were employed as underground uranium miners (n = 413), and therefore, were also excluded from
this analysis. After exclusions were applied, the final cohort consisted of 28,546 male uranium miners.
Int. J. Environ. Res. Public Health 2018, 15, 2413 3 of 12
A detailed description of the cohort has been published elsewhere [18,26]. Briefly, miners employed
between 1954 and 1996 were identified from the Mining Master File (MMF) and National Dose Registry
(NDR) [18,26–29]. The MMF contains detailed work history data for all uranium miners up until 1986,
when it was discontinued. Since the MMF records stopped at 1986, the NDR was used to identify
miners up to the closure of the last mine in 1996. The NDR was created by the Radiation Protection
Bureau of Health Canada in 1951 to monitor workers that may be exposed to ionizing radiation.
Follow-up of this cohort was conducted through record linkages to the Canadian Mortality Database
for national mortality follow-up from 1954 to 2007, and to the Canadian Cancer Database for national
cancer incidence follow-up from 1969 to 2005. The linkage was then enhanced using the Historic
Summary Tax File. To avoid potential biases, all data linkage was conducted nationally by Statistics
Canada, blinded to exposure levels and case status.
2.2. Estimates of Radon Progeny Exposure
In the early years of mining (1954–1957), occupational exposures to radon decay products were
estimated by mine engineers using stationary area sampling [3,30]. After 1958, measurements of radon
decay products were conducted by mine operators in different areas of the mines, including heading,
stopes, raises, and travelways [3,27,30]. Annual radon exposure was computed based on time spent
by individual miners in these different work areas and travelways, and is reported in working level
months (WLM). One working level (WL) is defined as 1.3 × 105 MeV of potential energy from alpha
particles per liter of air. An amount of 1 WLM is equal to an exposure to 1 WL for 170 h. All exposures
were assigned to miners blinded to their lung cancer status.
2.3. Morphology and Histology
In Canada, each province and territory is responsible for maintaining databases of information
about residents diagnosed with cancer collated from health care utilization information, pathology
reports, and deaths certificates. This information is in turn collated nationally by the Canadian
Cancer Registry (CCR) and maintained by Statistics Canada [31,32]. Data from the CCR is used to
identify lung cancer cases for this study. This study only included incident cases where morphologic
information was available; cases without morphology codes (n = 18) were excluded from the stratified
analysis. Morphologic diagnoses were primarily confirmed using microscopic examination of tissue
samples; otherwise clinical techniques were employed, including laboratory diagnostics, radiology,
surgery, and endoscopy. Histologic coding was based on the International Classification of Diseases
for Oncology (ICD-O-3) of lung carcinoma grouped into: (1) squamous cell carcinoma (SqCC), (2)
adenocarcinomas (AdC), (3) small cell carcinoma (SmCC), (4) large cell carcinoma (LCC), and (5) other
or unspecified. Table 1 provides a summary of the morphology codes used for categorizing the cases
by histological subtypes.
Table 1. Classification of incident lung cancers by histology.
Lung Cancer Histology ICD-O-3 Morphology Codes
Squamous cells (SqCC) 8050–8053, 8060, 8070–8078, 8083–8084
Adenocarcinoma (AdC) 8140, 8211, 8230–8231, 8250–8260, 8323, 8480–8481, 8490, 8550–8551, 8570–8574, 8576
Large cells (LCC) 8010–8012, 8014, 8015, 8020, 8021, 8022, 8030, 8031, 8035, 8310, 8046
Small cells (SmCC) 8041–8045
Other or Unspecified Other specified carcinoma (8246), sarcoma (8800–8811, 8830, 8840–8921, 8990–8991,9040–9044, 9120–9133, 9150, 9540–9581), unspecified (8000–8005)
2.4. Statistical Analyses
To evaluate the risk of lung carcinoma associated with exposure to short lived radon progeny by
histological subtypes, complete exposure and follow-up history of the cohort was ascertained. Miners
contributed person-years from the latest of their date of first employment or 1 January 1969, until the
earliest of their date of death, 31 December 2005, or date of primary diagnosis of lung cancer. A cut-off
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age of 85 years was applied to minimize any bias caused by loss to follow-up. Person-years at risk (PYAR)
were cross-classified by attained age (<55, 55–<60, 60–<65, 65–<69, 70–<75,≥75 years), calendar period
(1969–1974, 1975–1995, >1995), and cumulative radon exposure in WLM (<1, 1–10, >10–20, >20–60, >60).
Categories for cumulative radon exposure, attained age, and calendar period were chosen to provide
an approximately equal distribution of cases across histological groups and a sufficient sample size to
provide reliable risk estimates. To account for the latency between exposure and cancer outcome, a range
of lag times (0, 5, 10, 15, and 20 years) were examined. The lag time that yielded the highest risk estimates
was chosen to capture the ideal exposure time window that will produce the strongest results [33].
To avoid bias caused by the healthy worker effect, internal cohort analyses were conducted using
Poisson regression to estimate the relative risk (RR) of lung cancer overall, and for the four histologic
subtypes of interest. Poisson regression with PROC GENMOD (SAS Version 9.4) was used to model
lung cancer risk as a function of cumulative radon exposure and covariates of interest. The general
form of the Poisson regression model is:
ln(I/I0) = β1X1 + β2X2 + . . . + βkXk, (1)
where X1, X2, . . . , Xk, are independent variables, I is the incidence rate for persons with specified
values X1, X2, . . . , Xk, I0 is the incidence rate in the control group, and β1, β2, . . . , βk are the estimated
regression coefficients. Exponentiation of the regression coefficients provides an estimate of the relative
risk (I/I0), controlling for the independent variables (attained age and calendar period). Wald-based
95% confidence intervals were calculated for all risk estimates.
The χ2 test for linear trend was used to assess the dose response relationship between cumulative
exposure to radon decay products and cancer outcomes. Given that the exposure variable in this study
was categorized into five groups (<1, 1–10, >10–20, >20–60, >60 WLM), the linear test for trend was
conducted by using the weighted mean dose for each category.
In order to examine cumulative radon exposure as a continuous variable, linear excess relative
risk (ERR) models were used, with the general form:
RR = 1 + βX1, (2)
where RR is the relative risk and β is the increase in ERR per unit increase of cumulative radon
exposure (WLM, X1). This model assumes a linear, no threshold association between cumulative
radon exposure and risk of incident lung cancer [3]. Estimates of ERR/WLM with Wald-based 95%
confidence intervals were modeled using the AMFIT module in EPICURE, and adjusted for attained
age and calendar period.
3. Results
The analysis was based on a cohort of 28,546 miners. Of these, 1274 miners were identified as
having a primary diagnosis of lung carcinoma. Table 2 demonstrates that on average, lung cancer cases
were slightly older than non-cases (33 ± 8.9 years, p < 0.01) when they started mining, and worked as
a miner for a longer period (5 ± 5.1 years) compared to the rest of the cohort (p < 0.01). 75% of the
lung cancer cases occurred among the 43% of miners that were first employed before 1960 when radon
levels were the highest due to poor ventilation practices (p < 0.01).
Table 3 shows the distribution of the lung cancer cases by histologic subtypes. Among the 1274
cases identified, 1256 had morphology codes from which the histologic group could be determined. In
total, there were 391 (31%) incident cases of SqCC, 249 (20%) incident cases of AdC, 225 (18%) incident
cases of LCC, and 181 (14%) incident cases of SmCC. In addition, there were 210 (17%) cases of the
extracted morphological codes that did not correspond to these four major groups, such as sarcoma,
which were categorized as other or unspecified. On average, SqCC and SmCC had the highest mean
cumulative radon exposure (51.4 and 55.6 WLM respectively); however, this was expected since they
also had the longest mean duration of employment (5.3 and 6.0 years, respectively). In contrast, AdC
had the lowest mean cumulative radon exposure (37 WLM), as explained by shorter mean duration
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of employment (4.2 years) and starting work in later years when ventilation practices had improved.
We also examined age at diagnosis by histologic subtypes (data not shown); however, there were no
statistical differences across cell types.
Table 4 provides results of the Poisson regression analyses. Risk estimates presented are with no
lag, 5-year lag, and 10-year lag periods. All estimates were adjusted for attained age and calendar period.
The results confirm that the relative risk of lung cancer incidence remains elevated among uranium
miners exposed to radon. Compared to the referent group (<1 WLM), those within the highest cumulative
exposure group (>60 WLM) had a two-fold increase in risk of lung cancer (RR = 2.03, 95% CI: 1.68–2.45).
Table 2. Characteristics of the Ontario Uranium Miners cohort.
Characteristics Casesn = 1274
Non-Cases
n = 27,272
Test for Difference
p-Value
Age at entry into study (Years)
Median 32 26
<0.0001Mean ± SD 32.85 ± 8.88 28.57 ± 8.53
Range 17–65 16–65
Total Duration of Employment (Years)
Median 3.0 2.5
<0.0001Mean ± SD 5.04 ± 5.10 4.01 ± 4.05
Range 0.5–31.0 0.5–32.0
Cumulative radon exposure (WLM)
Median 18.89 6.03
<0.0001Mean ± SD 45.86 ± 70.33 23.06 ± 45.06
Range 0–875.13 0–800.00
Birth year, n (%)
<1900 0 (0%) 26 (0.10%)
<0.0001
1900–1919 198 (15.54%) 2104 (7.71%)
1920–1939 950 (74.57%) 12,081 (44.30%)
1940–1959 125 (9.81%) 11,314 (41.49%)
≥1960 1 (0.08%) 1747 (6.41%)
Year first employed, n (%)
<1960 956 (75.04%) 11,780 (43.19%)
<0.0001
1960–1969 107 (8.40%) 2426 (8.90%)
1970–1979 157 (12.32%) 8496 (31.15%)
1980–1989 52 (4.08%) 4475 (16.41%)
≥1990 2 (0.16%) 95 (0.35%)
WLM = Working Level Months. p-value < 0.05 indicates a significant difference between cases and non-cases.
In general, increasing lag-time (from 0 to 10 years) increases the magnitude of the risk estimate,
suggesting it is a more appropriate latency period. Interpretations of results are therefore based on the
10-year lag (Table 4). When compared to the referent group (<1 WLM), AdC had the lowest relative risk
(RR = 1.49, 95% CI: 0.96–2.31) at the highest cumulative radon exposure (>60 WLM) among all histological
subtypes. In contrast, a nearly tripled risk for SmCC was observed for the same exposure comparison
(RR = 2.76, 95% CI: 1.67–4.57). Similarly, SqCC was strongly associated at the highest category of radon
exposure, compared to reference (RR = 2.29, 95% CI: 1.63–3.23). The increase in cancer risks for both
SmCC and SqCC were dose-dependent (p < 0.01) with increasing cumulative radon dose. Both LCC
and the other/unspecified categories also had significant associations with radon exposure, although the
magnitude of the association was smaller and the dose-response relationships were weaker.
The excess relative risk (ERR) was also computed to estimate the proportion of risk attributed to
radon exposure, adjusting for attained age and calendar period, with 10 year lag applied. Figure 1
summarizes the results of analyses of the Ontario Uranium Miners cohort showing the ERR per WLM
by histological group. The ERR/WLM was highest for SmCC (ERR/WLM = 0.15, p < 0.01) followed
closely by SqCC (ERR/WLM = 0.12, p < 0.01). In contrast, non-statistically significant excess risk
was observed for adenocarcinoma (ERR/WLM = 0.004, p = 0.07). As expected, the results of the ERR
analysis reflect the findings of the relative risk analysis.
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Table 3. Characteristics of lung cancer diagnosis by histology subtypes, Ontario uranium miners.
Characteristics Squamous Cells(n = 391)
Adenocarcinoma
(n = 249)
Large Cells
(n = 225)
Small Cells
(n = 181)
Other/Unspecified
(n = 210)
Age at entry into study (years)
Median 32 29 33 30 34
Mean ± SD 32.9 ± 8.4 30.8 ± 8.6 33.7 ± 9.3 31.8 ± 8.5 35.2 ± 9.3
Range 17–61 17–62 17–63 19–61 17–65
Total Duration of Employment (years)
Median 3.25 3 3 4 3
Mean ± SD 5.3 ± 5.2 4.2 ± 4.2 4.9 ± 4.7 6.0 ± 6.2 5.1 ± 5.2
Range 0.5–30 0.5–26.5 0.5–31 0.5–29 0.5–25.5
Cumulative radon exposure (WLM)
Median 22.6 14.9 16.3 23.1 18.6
Mean ± SD 51.4 ± 75.3 37.0 ± 61.2 41.9 ± 57.2 55.7 ± 77.4 43.3 ± 78.0
Range 0–759.2 0–579.0 0–267.3 0–355.9 0–875.1
Birth year, n (%)
<1900 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
1900–1919 60 (15.35%) 22 (8.84%) 41 (18.22%) 22 (12.15%) 48 (22.86%)
1920–1939 305 (78.01%) 192 (77.11%) 155 (68.89%) 138 (76.24%) 147 (70.00%)
1940–1959 26 (6.65%) 34 (13.65%) 29 (12.89%) 21 (11.60%) 15 (7.14%)
≥1960 0 (0%) 1 (0.40%) 0 (0%) 0 (0%) 0 (0%)
Year first employed, n (%)
<1960 306 (78.26%) 180 (72.29%) 156 (69.33%) 136 (75.14%) 160 (76.19%)
1960–1969 32 (8.18%) 20 (8.03%) 20 (8.89%) 16 (8.84%) 19 (9.05%)
1970–1979 39 (9.97%) 35 (14.06%) 39 (17.33%) 23 (12.71%) 21 (10.00%)
1980–1989 14 (3.58%) 12 (4.82%) 10 (4.44%) 6 (3.31%) 10 (4.76%)
≥1990 0 (0%) 2 (0.80%) 0 (0%) 0 (0%) 0 (0%)
WLM = Working Level Months. Percentages may not add up to exactly 100 percent due to rounding error.
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Table 4. Risks associated with cumulative exposure to radon progeny in working level months by lung cancer histology.
Cumulative Exposure to
Radon Progeny (WLM)
No Lag 5 Year Lag 10 Year Lag
Cases (n) Relative Risk *(95% CI)
Test for Linear
Trend p-Value Cases (n)
Relative Risk *
(95% CI)
Test for Linear
Trend p-Value Cases (n)
Relative Risk *
(95% CI)
Test for Linear
Trend p-Value
All Lung Cancers
<1 188 Reference
<0.0001
188 Reference
<0.0001
197 Reference
<0.0001
1–10 290 0.91 (0.75, 1.09) 290 1.00 (0.83, 1.21) 286 1.05 (0.87, 1.26)
10–20 185 1.03 (0.84, 1.27) 186 1.13 (0.92, 1.39) 183 1.17 (0.95, 1.44)
20–60 313 1.30 (1.08, 1.57) 312 1.40 (1.16, 1.68) 313 1.46 (1.21, 1.76)
>60 298 1.84 (1.52, 2.22) 298 1.98 (1.64, 2.40) 295 2.03 (1.68, 2.45)
Squamous cells
<1 49 Reference
<0.0001
49 Reference
<0.0001
54 Reference
<0.0001
1–10 87 0.99 (0.69, 1.40) 87 1.03 (0.72, 1.47) 83 1.01 (0.71, 1.43)
10–20 52 1.01 (0.68, 1.50) 52 1.06 (0.71, 1.57) 52 1.06 (0.72, 1.57)
20–60 97 1.37 (0.96, 1.94) 97 1.42 (1.00, 2.02) 96 1.40 (0.99, 1.98)
>60 106 2.20 (1.55, 3.12) 106 2.29 (1.62, 3.25) 106 2.29 (1.63, 3.23)
Adenocarcinoma
<1 44 Reference
0.2168
44 Reference
0.2471
45 Reference
0.1736
1–10 61 0.88 (0.59, 1.30) 61 0.99 (0.67, 1.46) 61 0.95 (0.64, 1.41)
10–20 44 1.18 (0.77, 1.81) 44 1.26 (0.82, 1.95) 43 1.28 (0.84, 1.97)
20–60 56 1.18 (0.78, 1.77) 56 1.28 (0.85, 1.92) 56 1.28 (0.85, 1.92)
>60 44 1.37 (0.89, 2.13) 44 1.49 (0.96, 2.31) 44 1.49 (0.96, 2.31)
Large cells
<1 36 Reference
0.0088
36 Reference
0.0087
39 Reference
0.0148
1–10 56 0.92 (0.60, 1.40) 56 1.03 (0.67, 1.57) 55 1.07 (0.7, 1.62)
10–20 27 0.79 (0.48, 1.31) 27 0.88 (0.53, 1.46) 26 0.83 (0.5, 1.39)
20–60 55 1.20 (0.78, 1.86) 55 1.32 (0.85, 2.04) 56 1.43 (0.93, 2.19)
>60 51 1.68 (1.08, 2.62) 51 1.84 (1.18, 2.88) 49 1.72 (1.09, 2.69)
Small cells
<1 28 Reference
<0.0001
28 Reference
<0.0001
28 Reference
<0.0001
1–10 34 0.77 (0.46, 1.27) 34 0.87 (0.52, 1.44) 35 1.07 (0.64, 1.77)
10–20 26 1.10 (0.64, 1.90) 27 1.28 (0.74, 2.20) 26 1.34 (0.77, 2.35)
20–60 47 1.52 (0.94, 2.47) 46 1.64 (1.00, 2.69) 46 1.88 (1.15, 3.09)
>60 46 2.28 (1.39, 3.73) 46 2.50 (1.52, 4.12) 46 2.76 (1.67, 4.57)
Other/ Unspecified
<1 29 Reference
0.0339
29 Reference
0.0323
29 Reference
0.0248
1–10 45 0.85 (0.53, 1.36) 45 0.94 (0.58, 1.50) 45 1.05 (0.65, 1.69)
10–20 36 1.16 (0.71, 1.91) 36 1.30 (0.79, 2.14) 36 1.51 (0.92, 2.49)
20–60 51 1.19 (0.74, 1.89) 51 1.25 (0.78, 2.01) 52 1.34 (0.83, 2.17)
>60 49 1.65 (1.03, 2.65) 49 1.78 (1.10, 2.87) 48 1.93 (1.19, 3.13)
* Relative risk estimates are adjusted for attained age and calendar period; WLM = Working Level Months; CI = Confidence Interval; p-value < 0.05 indicates a positive trend in relative risk
as cumulative WLM increases.
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4. Discussion
Similar to previous studies, our analysis confirms the increased risk of lung cancer with increasing
cumulative exposure to radon decay products (Ptrend < 0.01). More importantly, this study found
significantly higher risks for SqCC and SmCC than other histologic subtypes. Furthermore, the
increased risk for SqCC and SmCC showed a strong dose-response relationship (Ptrend < 0.01).
Conversely, diagnosis of adenocarcinoma was not significantly associated with radon at any exposure
level (Ptrend = 0.17). This study contributes to the literature by providing empirical evidence showing
lung cancer incidence associated with exposure to radon decay products for different histological
subtypes among the Ontario Uranium Miners.
Our finding of elevated risk for SqCC and SmCC is consistent with previous studies and further
provides empirical evidence that certain lung cell types are more radiosensitive than others [23,34].
The differences in risk estimates across histologic groups may possibly be explained by oxidative
stress from oxy-radicals produced by chronic radon exposure. Over-production of oxy-radicals is
known to cause pulmonary inflammation, which in turn, leads to overproduction of cytokines and
chemokines [35]. In a genome-wide association study of the Saccomanno Uranium Miner cohort, a
sequence variation of the interleukin-6 promoter region was found to be significantly associated with
increased risk of SqCC and a shorter latency period, among radon-exposed miners [35]. This suggests
that there in indeed epigenetic responses to environmental radon exposure, which may, in part, account
for the differences in risk observed across histologic groups. The process of radon decay emits alpha
particles which have a high linear energy transfer, but very low penetrance. Mechanistically, epithelial
cells that are the front line barrier to alpha radiation would receive the majority of the dose, and would
therefore be at highest risk of tumorigenesis. These findings suggest that the radon decay process can
more readily initiate DNA damage of epithelial tissues, such as squamous and small cell carcinomas
through direct irradiation compared to adenocarcinoma [25].
Studies of residential radon have previously quantified the association between radon exposure
and histologic subtypes of lung cancer. Barros-Dios et al. (2012) found an elevated risk of lung
cancer with radon exposure across all histologic subtypes [36]. Similarly, they found the highest risk
associated with other cell types and SmCC, but contrary to our findings, the elevated risk in SqCC
was non-significant. That study, however, was focused on lower concentrations of radon exposure in
residential settings, which may account for some of the differences between our findings. A recent
systematic review also found that exposure to residential radon had the strongest association with
SmCC compared to any other histological group among the general population and miners, which is
consistent with our findings [37].
A major limitation of these analyses is the lack of individual level smoking information for this
cohort, as it is the leading cause of lung cancer. Studies of lung cancer often adjust for smoking
status, and it has been found to have synergistic interactions with radon exposure, underscoring its
importance in studies of lung cancer risk [21]. The risks for each histologic group follow a similar
pattern to the risks associated with smoking, which may be partially explained by the interaction
between radon exposure and smoking status. Unfortunately, this hypothesis cannot be tested within
the Ontario Uranium Miners cohort. Although limited by a lack of smoking data, the study has
significant strengths including its quantitative exposure assessment, access to national tumor registry
data, and large sample size, which facilitated our investigation of the dose-response relationship across
the four major histological subtypes of lung cancer.
An issue with using a single lag time is that the latency period for lung cancer can range from 5 to
20 years, which is based on a number of factors, perhaps including the histologic group. Using a single
lag time may not provide enough information, as this analysis demonstrates that some histologic
groups have peak risk with 5-year lag, and others with 10-year lag. The analyses also did not consider
the effect of sex on the risk estimates. Because there were so few female uranium miners in Ontario
(n = 413), they were excluded from the risk analysis in this study.
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Another strength of this study is that incident cases are used rather than deaths. Because tumour
registry data is much more detailed than death certificates, using incident cases permits analysis
by histologic group. Furthermore, incident cases are not influenced by changes in cancer treatment
practices over time that can impact survival duration following initial diagnosis. In this study, the
national Canadian Cancer Registry linkage contained ICD-O-3 morphology coding, allowing for
analysis of incident cases. From the morphology coding, the incident cases may be grouped by
histology for the stratified analysis, making our cohort amendable to analyses similar to the German
cohort [21,38].
Historically, most studies have examined lung cancer mortality, where differences across histologic
groups cannot be examined due to the lack of information on tumour morphology on death certificates.
The lack of cancer registries with appropriate morphology data in other jurisdictions, more recent and
shorter follow-up periods, and insufficient statistical power may also be reason for sparse literature on
stratified analyses by histological subtype.
Future work with these data includes investigating the inverse dose rate effect in this cohort,
stratified by histologic subtype; the same cumulative dose protracted over a longer time may result in
certain histologic subtypes more frequently than others, and further investigation is warranted. This
analysis also demonstrates the capacity for histologic analyses for other incident cancers; however, the
issue of statistical power may limit the ability to stratify less common cancers.
5. Conclusions
This is the first comprehensive study of lung cancer risk associated with exposure to radon decay
products evaluated by histological subtypes among a cohort of Ontario Uranium Miners. Based
on our analysis of the Ontario Uranium Miners cohort file, we found that the incidence of lung
cancer was strongly associated with occupational radon exposure. Within this cohort, the highest
risk was observed for small cell lung carcinomas, followed by squamous cell lung carcinomas, large
cell lung carcinomas, and lastly adenocarcinoma. While the results of our study is limited by the
lack of smoking information, the excess risks observed for the different histological subtypes for our
study is in agreement with the literature. Findings from this study contribute to the growing body
of empirical evidence on lung carcinoma associated with exposure to short-lived radon progeny by
histological subtypes.
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